1. Home
  2. JANX

JANX

Janux Therapeutics Inc.

Logo Janux Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Founded: 2017 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 2.6B IPO Year: 2021
Target Price: $58.14 AVG Volume (30 days): 880.5K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.32 EPS Growth: N/A
52 Week Low/High: $5.65 - $58.69 Next Earning Date: 05-07-2024
Revenue: $8,083,000 Revenue Growth: -6.14%
Revenue Growth (this year): -75% Revenue Growth (next year): -35.13%

Share on Social Networks: